Related Experiment Video
Updated: May 9, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Secondhand smoke exposure and intermittent claudication: a Scotland-wide study of 4231 non-smokers
Liya Lu1, Daniel F Mackay, Jill P Pell
1Department of Public Health, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Objective:
Active smoking is an important risk factor for peripheral arterial disease. In contrast, published evidence on the association with secondhand smoke (SHS) is very limited. The aim of this study was to examine the association between SHS exposure and intermittent claudication (IC) among middle aged non-smokers.
Design:
Multivariate logistic regression analyses were used to adjust for potential confounders.
Setting:
The Scottish Health Survey, a pan-Scotland, representative survey of the general population.
Patients:
We conducted a cross-sectional study using the Scottish Health Surveys undertaken between 1998 and 2010. Inclusion was restricted to participants aged > 45 years.
Main Outcome Measures:
Of the 4231 confirmed non-smokers (self-reported non-smokers with salivary cotinine concentrations < 15 ng/mL), 134 (3.2%) had IC based on the Edinburgh Claudication Questionnaire.
Results:
There was evidence of a dose relationship, whereby the risk of IC increased with increasing cotinine concentration. Following adjustment for potential confounders, participants with a cotinine concentration ≥ 2.7 ng/mL were still significantly more likely to have IC (OR 1.76, 95% CI 1.04 to 3.00; p = 0.036) compared with those with a cotinine concentration < 0.7 ng/mL. Among non-smokers, 5.6% (95% CI -0.8% to 11.7%) of cases of IC were attributable to cotinine concentrations ≥ 2.7 ng/mL and a further 3.6% (95% CI -6.6% to 12.8%) to cotinine concentrations of 0.7-2.6 ng/mL.
Conclusions:
As with coronary heart disease and stroke, SHS exposure was independently associated with IC. Our findings add to the published evidence in support of protecting the general public from SHS exposure.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Peripheral Artery Disease III: Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema

